- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02914587
Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study
February 9, 2017 updated by: Restoration Robotics, Inc.
To investigate and compare the safety and effectiveness of the ARTAS™ System to manual hair follicle implantation method following a nine month period of post-procedure evaluation.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This comparative study is a multi-center, prospective, blinded, randomized controlled clinical study where subjects act as their own control.
The purpose of this study is to demonstrate that the ARTAS System is safe and effective for implanting follicular hair units.
Patients will be followed for a nine months period of time.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Berman Skin Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
29 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Subject is male with clinical diagnosis of androgenetic alopecia with Norwood-Hamilton grade of IV-VI;
- Subject is 29 to 70 years old;
- Subject has black or brown hair color;
- Subject has straight hair;
- Subject agrees to cut hair short (about 1-1.4 mm) on the scalp in the designated study areas for harvesting and implantation;
- Subject agrees to have 6 dot tattoos placed on scalp;
- Subject is able to understand and provide written consent; and
- Subject consents to post-operative follow-up per protocol.
Exclusion Criteria:
- Subject has prior history of scalp reduction surgery(s);
- Subject has prior history of hair restoration procedure(s) using the strip excision technique;
- Subject has bleeding diathesis;
- Subject has active use of anti-coagulation medication;
- Subject has used finasteride in the previous 6 months, or plans to use finasteride during the study;
- Subject has used minoxidil in the previous 2 weeks, or plans to use minoxidil during the study; or
- Subject has any other condition that, in the opinion of the investigator, makes the subject inappropriate to take part in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: ARTAS System
Implantation with the ARTAS System.
|
|
ACTIVE_COMPARATOR: Manual Implantation
Implantation manually.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hair Survival rate 9-months post procedure
Time Frame: 9 month
|
Hair survival rate
|
9 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2016
Primary Completion (ANTICIPATED)
October 1, 2017
Study Completion (ANTICIPATED)
October 1, 2017
Study Registration Dates
First Submitted
September 19, 2016
First Submitted That Met QC Criteria
September 23, 2016
First Posted (ESTIMATE)
September 26, 2016
Study Record Updates
Last Update Posted (ACTUAL)
February 13, 2017
Last Update Submitted That Met QC Criteria
February 9, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Androgenic Alopecia
-
Galderma R&DCompletedFemale Pattern Hair Loss, Androgenic AlopeciaUnited States
-
Galderma R&DCompletedMale Pattern of Hair Loss, Androgenic AlopeciaUnited States
-
Clinica Dermatologica Arbache ltdaRecruiting
-
Kasr El Aini HospitalRecruiting
-
Beauty HealthCallender Center for Clinical Research; ATS Clinical Research; Skin Surgery Medical... and other collaboratorsCompletedAndrogenic AlopeciaUnited States
-
Mohammed Abd El Mawgoud AmerRecruiting
-
Yale UniversityCompletedAndrogenic AlopeciaUnited States
-
Jinan University GuangzhouCompleted
-
Dong-A ST Co., Ltd.CompletedAndrogenic AlopeciaKorea, Republic of
-
Pusan National University HospitalCompleted
Clinical Trials on ARTAS System
-
Restoration Robotics, Inc.Completed
-
Columbia UniversityNational Institute on Drug Abuse (NIDA); University of Miami; Weill Medical College... and other collaboratorsRecruitingHIV Prevention | Opioid Use | HCV | Intravenous Drug UsageCanada, United States
-
Loma Linda UniversityGilead SciencesRecruiting
-
Centers for Disease Control and PreventionConnecticut State, Department of Mental Health and Addiction Services; Massachusetts... and other collaboratorsCompletedHuman Immunodeficiency VirusUnited States
-
University of Alabama at BirminghamJohns Hopkins University; Birmingham AIDS Outreach; AIDS UnitedCompletedHIV Infection | HIV Care Loss to Followup
-
ResMedCompleted
-
Federal University of São PauloCompletedAdverse Reaction to Systemic AgentsBrazil
-
KineticureCompletedOsteoarthritis | Knee PainUnited States
-
Smith & Nephew, Inc.CompletedDiabetic Foot Ulcers | Venous Leg UlcersUnited States, Canada